 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | BD |
| Street 1: | 6th floor Signature Towers |
| Street 2: | South City-I |
| City: | Gurgaon |
| Province: | |
| Post Code: | 122001 |
| Country: | India |
| Phone: | +919811846766 |
| Email: | lalita_shankar@bd.com |
| Web Site: | http://www.bd.com |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Private sector |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | None |
| Is your organization legally registered in your country: | Yes |
| Organization Reach: | International |
| Organization Description: | |
| Founded in 1897, BD is an international medical technology company with operations in over 100 countries. It is the wordl's leading upplier of medical devices and a leading innovator in injection and infusion baseddrug delivery to reducethe spread of infection, enhance diabetes treament ad advance drug delivery. The BD Diagnostics segment focuses on imprving health outcomes for patients by providing laboratorieswith solutions that enhance lab system prodictivity, improve quality and inform medical devisions. BD's rapiddiagnostic assays and microorganizm identifying and drug susceptibility systems include use of liquid based cytology systems for accurate TB diagnosis. As a global leader in TB innovations, BD continues to support the stop TB partnrship in advocating for tigher regulation of diagnostics, increased ttention to quality ssurance in laboratories and greater engagemet of the privte sector to deliver innovative products ad approaches in India and across the world. |
|
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 100 + |
| Number of part-time staff who are directly involved with TB: | 26 - 50 |
| Number of volunteers who are directly involved with TB: | 11 - 25 |
| What is your organization's annual budget (USD) dedicated to TB? | >$10 MIL |
| How did you hear about the Stop TB Partnership: | Stop TB communications |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | India |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| BD is an active contributor to the RNTCP prgram as a private sector inducstry partner. BD's partnership with FIND which is closely associated with Govt of Inia's RNTCP program is tasked to build capacity of over 33 centers of excellence (COE) across India in accurae TB diagnosis and service delivery systems. | |
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which WHO region is the main focus of your work: | South East Asian |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Argentina Australia Austria Azerbaijan Bahamas Bangladesh Belgium Brazil Cambodia Canada Chile China Colombia Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Denmark Dominican Republic Ecuador Egypt Eritrea Estonia Ethiopia Finland France Germany Ghana Greece Guatemala Haiti Lao People's Democratic Republic Malaysia Maldives Mexico Monaco Morocco Mozambique Namibia Nepal Netherlands New Zealand Nicaragua Norway Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Republic of Korea Republic of Montenegro South Africa Spain Sri Lanka Sudan Sweden Switzerland Thailand Trinidad and Tobago Tunisia Turkey United Arab Emirates United States of America Uruguay Venezuela Viet Nam Yemen Zambia |
Specializations | |
|
Advocacy, communication and social mobilization Delivery of health services and care Provision of drugs, diagnostics and commodities Research and Development Technical Assistance |
Specializations in Countries | |
| Provision of drugs, diagnostics and commodities | Argentina |
| Provision of drugs, diagnostics and commodities | Australia |
| Provision of drugs, diagnostics and commodities | Austria |
| Provision of drugs, diagnostics and commodities | Azerbaijan |
| Provision of drugs, diagnostics and commodities | Bahamas |
| Provision of drugs, diagnostics and commodities | Bangladesh |
| Provision of drugs, diagnostics and commodities | Belgium |
| Provision of drugs, diagnostics and commodities | Brazil |
| Provision of drugs, diagnostics and commodities | Cambodia |
| Provision of drugs, diagnostics and commodities | Canada |
| Provision of drugs, diagnostics and commodities | Chile |
| Provision of drugs, diagnostics and commodities | China |
| Provision of drugs, diagnostics and commodities | Colombia |
| Provision of drugs, diagnostics and commodities | Czech Republic |
| Provision of drugs, diagnostics and commodities | Democratic People's Republic of Korea |
| Provision of drugs, diagnostics and commodities | Denmark |
| Provision of drugs, diagnostics and commodities | Dominican Republic |
| Provision of drugs, diagnostics and commodities | Ecuador |
| Provision of drugs, diagnostics and commodities | Egypt |
| Provision of drugs, diagnostics and commodities | Estonia |
| Provision of drugs, diagnostics and commodities | Ethiopia |
| Provision of drugs, diagnostics and commodities | Finland |
| Provision of drugs, diagnostics and commodities | France |
| Provision of drugs, diagnostics and commodities | Germany |
| Provision of drugs, diagnostics and commodities | Ghana |
| Provision of drugs, diagnostics and commodities | Greece |
| Provision of drugs, diagnostics and commodities | Guatemala |
| Provision of drugs, diagnostics and commodities | Haiti |
| Provision of drugs, diagnostics and commodities | Lao People's Democratic Republic |
| Provision of drugs, diagnostics and commodities | Malaysia |
| Provision of drugs, diagnostics and commodities | Mexico |
| Provision of drugs, diagnostics and commodities | Monaco |
| Provision of drugs, diagnostics and commodities | Morocco |
| Provision of drugs, diagnostics and commodities | Namibia |
| Provision of drugs, diagnostics and commodities | Nepal |
| Provision of drugs, diagnostics and commodities | Netherlands |
| Provision of drugs, diagnostics and commodities | New Zealand |
| Provision of drugs, diagnostics and commodities | Norway |
| Provision of drugs, diagnostics and commodities | Papua New Guinea |
| Provision of drugs, diagnostics and commodities | Paraguay |
| Provision of drugs, diagnostics and commodities | Peru |
| Provision of drugs, diagnostics and commodities | Philippines |
| Provision of drugs, diagnostics and commodities | Poland |
| Provision of drugs, diagnostics and commodities | Portugal |
| Provision of drugs, diagnostics and commodities | Republic of Korea |
| Provision of drugs, diagnostics and commodities | South Africa |
| Provision of drugs, diagnostics and commodities | Spain |
| Provision of drugs, diagnostics and commodities | Sri Lanka |
| Provision of drugs, diagnostics and commodities | Sweden |
| Provision of drugs, diagnostics and commodities | Switzerland |
| Provision of drugs, diagnostics and commodities | Thailand |
| Provision of drugs, diagnostics and commodities | Trinidad and Tobago |
| Provision of drugs, diagnostics and commodities | United Arab Emirates |
| Provision of drugs, diagnostics and commodities | United States of America |
| Provision of drugs, diagnostics and commodities | Venezuela |
| Provision of drugs, diagnostics and commodities | Viet Nam |
| Provision of drugs, diagnostics and commodities | Zambia |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
DOTS Expansion and Enhancement: Atively engaged in advocacy for appropriate and accurate diagnosis andtreatment Laboratory Strengthening: engaed in caapcity development of Centers of excellence designated by the national TB program for better diagnosis of TB and quality assurance New Diagnostics: working on new technologies for diagnosis incuding use of liquid culture systems for efficient diagnosis |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | September 14, 2011 |
| Last updated: | September 28, 2011 |